CIK 0001644963
- Non-accelerated filer
- Smaller reporting company
AVENUE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATXI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474113275
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Fortress Biotech, Inc. 10% owner | Grant or award | +111,209 | 439,733 | ||
| 2025-03-31 | Fortress Biotech, Inc. 10% owner | Grant or award | +33,724 | 328,524 | ||
| 2024-04-16 | Fortress Biotech, Inc. 10% owner | Grant or award | +413,507 | 3,547,393 | ||
| 2024-01-02 | Fortress Biotech, Inc. 10% owner | Grant or award | +2,101,496 | 3,133,886 | ||
| 2023-09-08 | Fortress Biotech, Inc. 10% owner | Purchase | +418,410 | $0.72 | $301K | 1,032,390 |
| 2023-03-31 | Fortress Biotech, Inc. 10% owner | Grant or award | +52,419 | 613,980 | ||
| 2023-01-03 | Fortress Biotech, Inc. 10% owner | Grant or award | +231,316 | 561,561 | ||
| 2022-12-31 | Fortress Biotech, Inc. 10% owner | Grant or award | +90,909 | 330,245 |
Page 1 of 1 · 8 trades